NASDAQ:BVXV

BiondVax Pharmaceuticals Earning Date

USA |NASDAQ |USD

BVXV Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 31, 2021 (est) Sep 30, 2021 - $-0.26 $-0.39
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 31, 2021 (est) Sep 30, 2021 - $0.00 $0.00

Biondvax Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

BVXV Earnings Date & History Chart

BVXV Earnings & Revenue Forecast

BVXV Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 0 $0.00 $0.00 $0.00

BVXV Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-6.00 $-6.00 $-6.00

BVXV Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.00 $0.00 $0.00

BVXV Earnings Date & Revenue History

BVXV Earnings History

|
Show More
Show More

BVXV Revenue History

|
Show More
Show More

Biondvax Pharmaceuticals Next Earnings Date & Report

BVXV Aug 2021 (FQ) Earnings Date & Report Preview

BVXV's next estimated earnings date (based on same quarter last year's report date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

Biondvax Pharmaceuticals Previous Earnings Dates & Reports

BVXV Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Biondvax Pharmaceuticals's previous earnings date was Aug 27, 2021 for its fiscal quarter ended Jun 30, 2021.

BVXV's earnings per share (EPS) was $-0.26.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -0.04%, and lower than the same period a year before (Jun 2020) by 772.79%.

Revenues were $0.00.

The company reported a net income of $-11.99M.

BVXV ended the quarter with $71.06M in total debt, an increase of 3.04% compared to the previous quarter, and a decrease of -42.10% compared to the same quarter a year before.

BVXV Previous Earnings Date & Report Recap: Dec 2020 (FY)

Biondvax Pharmaceuticals's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

BVXV's earnings per share (EPS) was $-0.74.

Revenues were $0.00.

The company reported a net income of $-4.46M.

Biondvax Pharmaceuticals reported a free cash flow of $-78.67M for its fiscal year, compared to $-84.49M a year ago.

The company ended the fiscal year with $67.16M in total debt, a decrease of -46.04% compared to the previous year.